Certara Stock News

RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.

Certara, Inc. (NASDAQ:CERT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 12:20 PM EDT Company Participants John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. I think we're on time here.

Certara, Inc. (NASDAQ:CERT ) Baird Global Healthcare Conference 2025 September 9, 2025 10:15 AM EDT Company Participants William Feehery - CEO & Director John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Conference Call Participants Joseph Vruwink - Robert W. Baird & Co. Incorporated, Research Division Presentation Joseph Vruwink Senior Research Analyst All right.

RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the availability of Pinnacle 21 Enterprise Plus.

RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:

Cerrado Gold Inc. (OTCQX:CRDOF) Q2 2025 Earnings Conference Call August 25, 2025 11:00 AM ET Company Participants Michael McAllister - Vice President of Investor Relations Mark Peter Brennan - CEO & Chairman Jason Brooks - Chief Financial Officer Conference Call Participants Operator Thank you for standing by. This is the conference operator.

Certara, Inc. (NASDAQ:CERT ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants John E. Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer William F.

Certara (CERT -3.35%), a leader in biosimulation software and Model-Informed Drug Development solutions, released its Q2 FY2025 earnings on August 6, 2025. The most notable news was a slight revenue beat, with reported GAAP revenue of $104.6 million, exceeding analyst expectations, but non-GAAP earnings per share (EPS) missed consensus by $0.03.